Study 2 | National Headache Foundation

Heads UP – Episode 88: Intracranial Hypertension and Aimovig (Erenumab)

New data has shown that Aimovig (erenumab) is effective in treating intracranial hypertension, also known as high-pressure headache or pseudotumor cerebri. Dr. Lindsay Burgarello Weitzel and Dr. Timothy Smith discuss this exciting news for people living with this condition.

Heads UP – Episode 78: Medical Update on Nocira

In this episode of Heads UP, Dr. Lindsay Weitzel talks with Dr. Tim Smith about Nocira, the latest device being trialed for migraine treatment. This interesting device works with your smartphone and utilizes puffs of air into your ear through…

Heads UP – Episode 72: Medical Update – VYEPTI

Medication Update – Lundebeck has issued a press release on their latest migraine medication – Vyepti. It is great news for those of us living with migraine disease. Dr. Tim Smith and Dr. Lindsay Weitzel discuss what the latest data…

Heads UP – Episode 69: New Drug Data Alert – Atogepant

New data was revealed this month on the upcoming gepant indicated for migraine prevention called Atogepant. Dr. Lindsay Weitzel questions Dr. Tim Smith about its safety and effectiveness in Episode 69 of Heads UP. How will we take it and…

Heads UP – EPISODE 68: The Latest Data on Combining Botox With Anti-CGRP Medications

There has been much debate about combination therapy with Botox and anti-CGRP monoclonal antibodies including Aimovig, Ajovy, and Emgality. The two medications were not originally studied together leaving physicians uncertain about prescribing practices and many insurance companies unwilling to pay…

Heads UP – Episode 64: A Call to Action to Achieve Equity in Headache Medicine

Watch Episode 64 of Heads UP: A Call to Action to Achieve Equity in Headache Medicine, and discover the importance of having your voice be heard. Dr. Lindsay Weitzel and Dr. Larry Charleston IV, discuss a timely Request for Information…

Perspectives from People with Migraine Disease

In recognition of Migraine and Headache Awareness Month, the National Headache Foundation today announced findings from its Perspectives from People with Migraine survey, which highlights experiences of people with migraine disease, the tradeoffs made to manage their disease with current therapies…

You are invited to the Migraine World Summit!

The Migraine World Summit is the largest patient event in the world for migraine and headache disorders. The Migraine World Summit will bring together 32 experts, including doctors and specialists, to share new treatments, research, and strategies to help you…

Those Most Impacted by Migraine Have the Poorest Access to Care

The National Headache Foundation has begun to conduct surveys with thousands of our patient members on important topics: affordability of care; meaningful migraine relief; satisfaction with medications and treatment; etc. The results are accumulating and we are beginning to analyze…

Are Your Migraine Keeping You Down? A Migraine Prevention Research Study is Enrolling Now!

The National Headache Foundation is providing the below information on this study as a public service to its members. Are your migraines keeping you down? A migraine prevention research study is enrolling now! You may qualify if you: Are between…

Study Finds Young People with Migraine More Likely to Have Vitamin Deficiencies

A recent study says that many young people with migraine have vitamin deficiencies, but researchers are not certain whether vitamin supplementation would help prevent migraine attacks. The study was conducted by Cincinnati Children’s Hospital Medical Center. The study found a…

Individuals Are Not Great at Determining Their Own Triggers

As Curelator Headache tracks the factors and symptoms for individuals’ headache and migraine, one thing is becoming clear: individuals are not great at determining their own triggers. Curelator Headache is a digital tool that guides individuals to identify personal triggers,…

‹ Previous Next ›